ContraFect to Present New Data at the 27th European Congress of Clinical Microbiology and Infectious Disease (ECCMID)
April 19, 2017 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - April 19, 2017) - ContraFect Corporation (NASDAQ: CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for...
ContraFect Chairman and CEO Steven C. Gilman Takes Temporary Medical Leave
March 13, 2017 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - March 13, 2017) - ContraFect Corporation (NASDAQ: CFRX), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody...
Lisa Ricciardi to Join Board of Directors
February 15, 2017 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - February 15, 2017) - ContraFect Corporation (NASDAQ: CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for...
ContraFect Provides Program Update
January 06, 2017 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - January 06, 2017) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect to Present at Biotech Showcase 2017 Conference
January 04, 2017 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - January 04, 2017) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect to Present at 28th Annual Piper Jaffray Healthcare Conference
November 23, 2016 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - November 23, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect to Present at The Lysin Meeting
November 10, 2016 16:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - November 10, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect Reports Third Quarter 2016 Financial Results and Provides Business Update
November 09, 2016 16:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - November 09, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect Announces Second Quarter 2016 Results
August 09, 2016 07:00 ET
|
ContraFect Corporation
YONKERS, NY --(Marketwired - August 09, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect Receives Designation as a Small and Medium Enterprise by the European Medicines Agency
August 04, 2016 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - August 04, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...